Genus plc
General ticker "GENSF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.2B (TTM average)
Genus plc does not follow the US Stock Market performance with the rate: -34.6%.
Estimated limits based on current volatility of 0.0%: low 31.07$, high 31.07$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2026-03-06, amount 0.15$ (Y0.97%)
Short-term GENSF quotes
Long-term GENSF plot
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | £689.70MM | £668.80MM | £672.80MM |
| Operating Expenses | £649.20MM | £662.40MM | £630.40MM |
| Operating Income | £40.50MM | £6.40MM | £42.40MM |
| Non-Operating Income | £-1.10MM | £-0.90MM | £-13.90MM |
| Interest Expense | £14.30MM | £21.30MM | £20.50MM |
| R&D Expense | £93.30MM | £27.80MM | £21.42MM |
| Income(Loss) | £39.40MM | £5.50MM | £28.50MM |
| Taxes | £16.60MM | £3.10MM | £12.63MM |
| Net Income(Loss)* | £33.30MM | £7.90MM | £15.87MM |
| Stockholders Equity | £569.40MM | £548.20MM | £475.60MM |
| Inventory | £85.10MM | £89.40MM | £80.90MM |
| Assets | £1,007.50MM | £1,028.90MM | £899.00MM |
| Operating Cash Flow | £50.40MM | £29.80MM | £67.20MM |
| Capital expenditure | £35.20MM | £24.70MM | £18.60MM |
| Investing Cash Flow | £-30.90MM | £-19.30MM | £-13.80MM |
| Financing Cash Flow | £-18.20MM | £-2.80MM | £-46.60MM |
| Earnings Per Share** | £0.51 | £0.12 | £0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.